385 related articles for article (PubMed ID: 10363793)
1. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors.
Untergasser G; Rumpold H; Hermann M; Dirnhofer S; Jilg G; Berger P
Exp Gerontol; 1999 Apr; 34(2):275-87. PubMed ID: 10363793
[TBL] [Abstract][Full Text] [Related]
2. Organ-specific expression pattern of the human growth hormone/placental lactogen gene-cluster in the testis.
Untergasser G; Kranewitter W; Schwärzler P; Madersbacher S; Dirnhofer S; Berger P
Mol Cell Endocrinol; 1997 Jun; 130(1-2):53-60. PubMed ID: 9220021
[TBL] [Abstract][Full Text] [Related]
3. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
[TBL] [Abstract][Full Text] [Related]
4. An unusual member of the human growth hormone/placental lactogen (GH/PL) family, the testicular alternative splicing variant hPL-A2: recombinant expression revealed a membrane-associated growth factor molecule.
Untergasser G; Hermann M; Rumpold H; Pfister G; Berger P
Mol Cell Endocrinol; 2000 Sep; 167(1-2):117-25. PubMed ID: 11000526
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
6. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.
Mariani S; Salvatori L; Basciani S; Arizzi M; Franco G; Petrangeli E; Spera G; Gnessi L
J Urol; 2006 Jun; 175(6):2072-7; discussion 2077. PubMed ID: 16697805
[TBL] [Abstract][Full Text] [Related]
7. Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia.
Fekete M; Redding TW; Comaru-Schally AM; Pontes JE; Connelly RW; Srkalovic G; Schally AV
Prostate; 1989; 14(3):191-208. PubMed ID: 2471961
[TBL] [Abstract][Full Text] [Related]
8. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
9. [The testis as eutopic production site of human growth hormone, placental lactogen and prolactin: possible autocrine/paracrine effects on testicular function].
Untergasser G; Kranewitter W; Walser F; Madersbacher S; Dirnhofer S; Berger P
Wien Klin Wochenschr; 1996; 108(17):541-6. PubMed ID: 8992787
[TBL] [Abstract][Full Text] [Related]
10. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development.
Handwerger S; Freemark M
J Pediatr Endocrinol Metab; 2000 Apr; 13(4):343-56. PubMed ID: 10776988
[TBL] [Abstract][Full Text] [Related]
11. De novo steroid biosynthesis in human prostate cell lines and biopsies.
Sakai M; Martinez-Arguelles DB; Aprikian AG; Magliocco AM; Papadopoulos V
Prostate; 2016 May; 76(6):575-87. PubMed ID: 26841972
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
14. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
[TBL] [Abstract][Full Text] [Related]
15. The stimulatory effect of growth hormone, prolactin, and placental lactogen on beta-cell proliferation is not mediated by insulin-like growth factor-I.
Billestrup N; Nielsen JH
Endocrinology; 1991 Aug; 129(2):883-8. PubMed ID: 1677331
[TBL] [Abstract][Full Text] [Related]
16. Coregulatory effects of epidermal growth factor, dihydrotestosterone, and prolactin on benign human prostatic hyperplasia tissue culture proliferation.
Janssen T; Petein M; van Velthoven R; De Decker R; Assenmacher C; Corbusier A; Pasteels JL; Kiss R; Schulman C
Prostate; 1997 Jan; 30(1):47-52. PubMed ID: 9018335
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone affects gene expression and proliferation in human prostate cancer cells.
Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
Int J Androl; 2011 Apr; 34(2):124-37. PubMed ID: 20546049
[TBL] [Abstract][Full Text] [Related]
18. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of GH and GHR isoforms in prostate cancer cell lines.
Chopin LK; Veveris-Lowe TL; Philipps AF; Herington AC
Growth Horm IGF Res; 2002 Apr; 12(2):126-36. PubMed ID: 12175650
[TBL] [Abstract][Full Text] [Related]
20. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
